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A N S W E R S
1. Esophago-airway fistulas occur rarely in
patients with AIDS despite the frequent occur-
rence of pulmonary and esophageal infections
[1]. The few reported cases have occured with
infections caused by Mycobacterium tuberculosis,
Mycobacterium avium-intracellulare, Candida albi-
cans, Nocardia species, cytomegalovirus and
herpes simplex virus [2–9]. The incidence of
the above infections is inversely related to the
level of cell-mediated immunity.
2. Figure 1 shows numerous acid-fast bacilli in the
tissue with a histiocytic host cell response. Some
of the bacilli are quite elongated, suggesting that
perhaps these are atypical mycobacteria. The
identity of the acid-fast bacilli in the biopsy
was unknown since a culture was not obtained
of the specimen. Because the therapy differs
greatly depending upon the species of myco-
bacteria other attempts at speciation were
undertaken. Blood cultures for acid-fast
micro-organisms were obtained as well as wash-
ings from the esophageal ulcer. The blood cul-
tures yielded M. avium-intracellulare. The
esophageal washings yielded M. avium-intracel-
lulare and Mycobacterium kansasii. Formalin-
fixed, paraffin-embedded tissue sections of the
esophageal biopsy were tested for DNA ampli-
fication. Nucleic acid was extracted from the
tissue sections and individual DNA amplifica-
tions were performed and probed for the detec-
tion of Mycobacterium [10,11]. For control
purposes human DNA and mycobacterial
DNA were assayed and detected before probing
for four species of Mycobacterium (M. avium, M.
tuberculosis, M. kansasii and M. gordonae). The
only Mycobacterium detected in the tissue sec-
tions from the esophageal ulcer was M. kansasii.
(However, the M. avium probe is the least effec-
tive of the four probes and it is possible that M.
avium could be present also.)
3. Although the patient refused any therapy a
suitable regimen for the M. avium-intracellulare
would include a macrolide, preferably clarithro-
mycin (azithromycin is also effective) and
ethambutol. A third agent, such as rifabutin
or amikacin may be added to this regimen.
Therapy for M. kansasii would include etham-
butol, rifampin and isoniazid.
4. Implementation of Highly Active AntiRetro-
viral Therapy (HAART) could possibly benefit
this patient by restoring the CD4 cell count and
reducing HIV-1 viremia.
D I S C U S S I O N
Esophageal infection occurs commonly in AIDS
patients and esophageal candidiasis may be the
initial manifestation of immune dysfunction [12].
Although Candida albicans is the most common
cause of esophagitis, mycobacterial esophagitis
 2002 Copyright by the European Society of Clinical Microbiology and Infectious Diseases
Figure 1 Tissue acid-fast stain of the esophageal biopsy.
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may be increasing in the AIDS population [9,13].
Common complications of esophagitis in these
patients include ulceration, perforation, fistula for-
mation, hemorrhage and stricture [6]. However,
esophageal inflammation is generally limited to
the mucosal surface, and transmural involvement
is rare [14]. There are several case reports of eso-
phago-airway fistulas in AIDS patients with M.
tuberculosis and M. avium-intracellulare. No cases of
esophago-airway fistula associated with M. kansa-
sii have been reported.
The patient reported here had disseminated M.
avium-intracellulare infection (demonstrated by
culture of the micro-organism from the blood)
which is a frequent opportunistic infection in AIDS
patients with profoundly depressed numbers of
CD4 cells (usually <50 cells/mL) [13]. Disease is
frequently found in the gastrointestinal tract
although any organ can be involved. Disease with
M. kansasii in AIDS patients most often presents
late in the course of the viral disease when CD4 cell
counts are<50 cells/mL, and it is usually confined
to the lung [15]. However, it is noteworthy that M.
kansasii has been considered the most virulent of
the non-tuberculous mycobacteria [14]. In the non-
immunosuppressed population M. kansasii causes
a pulmonary infection that is clinically indistin-
guishable from tuberculosis and culture evidence
of the micro-organism is often a sign of invasive
disease. It has been suggested that the presence of
mucosal thrush due to Candida may increase the
susceptibility of the mucosa to superinfection with
swallowed mycobacteria [3]. It is noteworthy that
the patient reported here had extensive oral thrush
and was treated for presumed esophageal thrush.
Our experience with this patient and review of
the literature suggest that esophago-airway fistula
may be common in cases of AIDS with extremely
low CD4 cell counts (<50 cells/mL), and that cul-
ture for mycobacteria should be performed on all
esophageal biopsies as the therapy for the different
Mycobacteria species is quite different.
A C K N O W L E D G M E N T
The authors thank J. Sanders Sevall of Specialty
Laboratories, Santa Monica, CA for the amplifica-
tion of DNA from human tissue and for probing
for the Mycobacteria species.
R E F E R E N C E S
1. Gottlieb MS, Groopman JE, Weinstein WE et al. The
acquired immunodeficiency syndrome. Ann Int
Med 1983; 99: 208–20.
2. Klapholz A, Wasser L, Stein S et al. Candida
pneumonia secondary to an acquired tracheoeso-
phageal fistula in a patient with AIDS. NY State J
Med 1988; 85: 279–80.
3. DeSilva R, Stoopack PM, Raufman JP. Esophageal
fistulas associated with mycobacterial infection in
patients at risk for AIDS. Radiology 1990; 175:
449–53.
4. Allen CM, Craze J, Grundy A. Case report:
tuberculous broncho-oesophageal fistula in the
acquired immunodeficiency syndrome. Clin Radiol
1991; 43: 60–2.
5. Cirillo N, Lyon D, Schuller AM. Tracheoesophageal
fistula complicating Herpes esophagitis in AIDS.
Am J Gastro 1992; 88: 587–9.
6. Macchiarini P, Delamare N, Beuzeboc P et al.
Tracheoesophageal fistula caused by Mycobacter-
ium tuberculosis adenopathy. Ann Thoracic Surg
1993; 55: 1561–3.
7. Porro GB, Parente F. Opportunistic infections of the
oesophagus in AIDS patients: clinical and thera-
peutic problems. J Intern Med 1993; 223: 107–10.
8. Rusconi S, Meroni L, Galli M. Tracheoesophageal
fistula in an HIV-1 positive man due to dual
infection of Candida albicans and Cytomegalo-
virus. Chest 1994; 106: 284–5.
9. Temes RT, Wong RS, Davis M et al. Esophago-airway
fistula in AIDS. Ann Thoracic Surg 1995; 60: 440–2.
10. Huang T-S, Liu Y-C, Lin H-H et al. Comparison of
the Roche Amplicor Mycobacterium Assay and
Digene SHARP Signal System with in-house PCR
and culture for detection of Mycobacterium tuber-
culosis in respiratory specimens. J Clin Microbiol
1996; 34: 3092–6.
11. Piersimoni C, Callegaro A, Nista D et al. Compara-
tive evaluation of two commercial amplification
assays for direct detection of Mycobacterium
tuberculosis complex in respiratory specimens. J
Clin Microbiol 1997; 35: 193–6.
12. Raufman JP. Odynophagia/dysphagia. Gastroenter-
ol Clin NA 1988; 17: 599–614.
13. Brodt HR, Enzensberger Kamps BS et al. Impact of
disseminated Mycobacterium avium complex in-
fection on survival of HIV-infected patients. Eur J
Med Res 1997; 24: 106–10.
14. Wolinsky E. When is an infection disease? Rev Infect
Dis 1981; 3: 1025–7.
15. Campo RE, Campo CE. Mycobacterium kansasii
disease in patients infected with human immuno-
deficiency virus. Clin Infect Dis 1997; 24: 1233–8.
190 Clinical Microbiology and Infection, Volume 8 Number 3, March 2002
 2002 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 8, 189–190
